SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-028848
Filing Date
2021-11-16
Accepted
2021-11-16 06:18:09
Documents
61
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 899663
2 ex31-1.htm EX-31.1 11991
3 ex31-2.htm EX-31.2 11273
4 ex32-1.htm EX-32.1 8225
  Complete submission text file 0001493152-21-028848.txt   5269894

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE eton-20210930.xsd EX-101.SCH 44150
6 XBRL CALCULATION FILE eton-20210930_cal.xml EX-101.CAL 49887
7 XBRL DEFINITION FILE eton-20210930_def.xml EX-101.DEF 253186
8 XBRL LABEL FILE eton-20210930_lab.xml EX-101.LAB 390738
9 XBRL PRESENTATION FILE eton-20210930_pre.xml EX-101.PRE 308430
10 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 685840
Mailing Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7278
Business Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7278 (847) 787-7361
Eton Pharmaceuticals, Inc. (Filer) CIK: 0001710340 (see all company filings)

IRS No.: 371858472 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38738 | Film No.: 211414037
SIC: 2834 Pharmaceutical Preparations